title: [The use of verapamil in the treatment of hemicrania without aura].
abstract: The efficacy of verapamil CR in migraine prophylaxis has been tested in an open study with 64 patients. The group of patients showed a significant decrease of the frequency, duration and severity score of their headache. All patients were treated for 3 months; thirty patients extended the treatment for 6 months without further improvement. In conclusion, verapamil CR is a useful drug with few side effects for migraine prophylaxis.
authors.affiliation: Divisione Neurologica, Ospedale S. Martino, Genova.
authors.forename: M
authors.initials: M
authors.lastname: Fonzari
authors.forename: D
authors.initials: D
authors.lastname: Santoloci
authors.forename: D
authors.initials: D
authors.lastname: Farinini
mesh_terms: D000293:Adolescent; D000328:Adult; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000453:epidemiology / Q000517:prevention & control*; D013997:Time Factors; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D014700:Verapamil
vernacular_title: Uso del verapamil nel trattamento dell'emicrania senza aura.